Other
Phase II
0
Pipeline Programs↗
32
Active Trials↗
60
Companies Involved↗
Phase II is an early-stage landscape with 0 programs across 60 companies. The most active players are AstraZeneca, Bristol-Myers Squibb, Bayer.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
229
clinical trials
Completed141 · 62%
Terminated26 · 11%
Unknown status25 · 11%
Recruiting13 · 6%
Active, not recruiting12 · 5%
Not yet recruiting7 · 3%
Other5 · 2%
Clinical Trials
Trial Activity
229 trials
Phase II Trial of Lung Chemoemobolization
Recruiting·—·Phase 2·NCT05672108·30 enrolled
A Phase II Study of CRT Combined With QL1706 in ESCC Patients
Recruiting·TTianjin Medical University Cancer Institute and Hospital·Phase 2·NCT05490719·39 enrolled
HIV-1 Infected Patients, Phase II Trial, Dual Combination Doravirine/Raltegravir Open Label
Recruiting·CCentre de Recherches et d'Etude sur la Pathologie Tropicale et le Sida·Phase 2·NCT04513626·150 enrolled
Phase II Study of FCN-159 in NF2 Nerve Sheath Tumors
Recruiting·—·Phase 2·NCT06553365·30 enrolled
Page 1 of 16
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)